These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35761758)

  • 21. Effects of environmental cleaning bundles on reducing healthcare-associated Clostridioides difficile infection: a systematic review and meta-analysis.
    Chau JPC; Liu X; Lo SHS; Chien WT; Wan X
    J Hosp Infect; 2020 Dec; 106(4):734-744. PubMed ID: 32861741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling the potential impact of administering vaccines against Clostridioides difficile infection to individuals in healthcare facilities.
    Toth DJA; Keegan LT; Samore MH; Khader K; O'Hagan JJ; Yu H; Quintana A; Swerdlow DL
    Vaccine; 2020 Aug; 38(37):5927-5932. PubMed ID: 32703744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential causal effect of contact precautions and isolation on Clostridioides difficile infection in the hyperendemic setting: Interrupted time-series analyses before and after implementation.
    Lee EH; Lee HS; Lee KH; Song YG; Han SH
    J Microbiol Immunol Infect; 2023 Oct; 56(5):1054-1063. PubMed ID: 37380552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healthcare associated
    Šuljagić V; Milenković B; Perić A; Jovanović D; Begović-Kuprešanin V; Starčević S; Tomić A; Vezmar Kovačević S; Dragojević-Simić V
    Libyan J Med; 2020 Dec; 15(1):1708639. PubMed ID: 31905110
    [No Abstract]   [Full Text] [Related]  

  • 25. Investigation of a cluster of Clostridium difficile infections in a pediatric oncology setting.
    Dantes R; Epson EE; Dominguez SR; Dolan S; Wang F; Hurst A; Parker SK; Johnston H; West K; Anderson L; Rasheed JK; Moulton-Meissner H; Noble-Wang J; Limbago B; Dowell E; Hilden JM; Guh A; Pollack LA; Gould CV
    Am J Infect Control; 2016 Feb; 44(2):138-45. PubMed ID: 26601705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.
    Demir SÖ; Kepenekli E; Akkoç G; Yakut N; Soysal A
    Turk J Pediatr; 2021; 63(6):1004-1011. PubMed ID: 35023650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced Clostridioides difficile infections in hospitalised older people through multiple quality improvement strategies.
    Dohrendorf CM; Unkel S; Scheithauer S; Kaase M; Meier V; Fenz D; Sasse J; Wappler M; Schweer-Herzig J; Friede T; Reichard U; Eiffert H; Nau R; Seele J
    Age Ageing; 2021 Nov; 50(6):2123-2132. PubMed ID: 34473822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the current state of infection prevention to prevent Clostridium difficile infection: a human factors and systems engineering approach.
    Yanke E; Zellmer C; Van Hoof S; Moriarty H; Carayon P; Safdar N
    Am J Infect Control; 2015 Mar; 43(3):241-7. PubMed ID: 25728149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in time-to-testing and time-to-isolation between community-onset and hospital-onset Clostridioides difficile cases at a tertiary care VA medical center.
    Hostler CJ; Bertumen JB; Park LP; Wilkins SB; Woods CW
    Am J Infect Control; 2020 Oct; 48(10):1148-1151. PubMed ID: 31911067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of control measures against an outbreak due to
    Sosa-Hernández O; Matías-Téllez B; González-Martínez J; Juárez-Vargas R; González-González NE; Estrada-Hernández A; Ruíz-Santana M; Bravata-Alcántara JC; Bello-López JM
    J Prev Med Hyg; 2021 Jun; 62(2):E508-E513. PubMed ID: 34604593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Certain Rooms in Intensive Care Units May Harbor Risk for
    Danehower S; Lazorko J; Kaplan LJ; Fegley M; Jablonski J; Owei L; Ziegler MJ; Pisa M; Pegues D; Pascual JL
    Surg Infect (Larchmt); 2022 Mar; 23(2):159-167. PubMed ID: 35020481
    [No Abstract]   [Full Text] [Related]  

  • 33. Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure.
    Johnson SW; Brown SV; Priest DH
    Clin Infect Dis; 2020 Aug; 71(5):1133-1139. PubMed ID: 31560051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship.
    Savage TJ; Sandora TJ
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S64-S68. PubMed ID: 34791402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Appropriate cleaning reduces potential risk of spore transmission from patients with Clostridioides difficile infection treated in outpatient infusion centers.
    Schroeder CP; Hengel RL; Nathan RV; Ritter TE; Obi EN; Lancaster C; Van Anglen LJ; Garey KW
    Anaerobe; 2022 Oct; 77():102617. PubMed ID: 35940371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and Outcomes of Patients With Healthcare Facility-Onset Clostridioides difficile Infection.
    Eberly MD; Susi A; Adams DJ; Love CS; Nylund CM
    Mil Med; 2022 Jul; 187(7-8):e915-e920. PubMed ID: 33772561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between Nutrition Protocol with
    Sato T; Kudo D; Kushimoto S
    Surg Infect (Larchmt); 2022 Jun; 23(5):483-488. PubMed ID: 35647891
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of an aerosolized hydrogen peroxide disinfection system for the reduction of Clostridioides difficile hospital infection rates over a 10 year period.
    Truitt CL; Runyan DA; Stern JJ; Tobin C; Goldwater W; Madsen R
    Am J Infect Control; 2022 Apr; 50(4):409-413. PubMed ID: 35307211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating the effect of active detection and isolation on
    Reagan KA; Chan DM; Vanhoozer G; Bearman G
    Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1614-1619. PubMed ID: 36912338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An agent-based simulation model for Clostridium difficile infection control.
    Codella J; Safdar N; Heffernan R; Alagoz O
    Med Decis Making; 2015 Feb; 35(2):211-29. PubMed ID: 25112595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.